,bcr_patient_uuid,patient_ID,new_tumor,new_tumor_event_site,new_tumor_event_site_other,days_to_progression
1,4EFEBE0B-EA06-4189-BE34-5C191F69D1F6,TCGA.2G.AAEW,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,143
2,E03C99F2-93CB-457F-8A77-D600F292E313,TCGA.2G.AAF6,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,810
3,A9C10A1D-EF0B-4A4E-8433-522A9E04796E,TCGA.2G.AAF8,NEW PRIMARY TUMOR,TESTES,NA,3149
4,A9C10A1D-EF0B-4A4E-8433-522A9E04796E,TCGA.2G.AAF8,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,3234
5,1D25C24E-BD3C-4023-85C1-B158F76324F1,TCGA.2G.AAFE,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,617
6,630C683D-D1A2-4BEC-AA20-38EF59227D97,TCGA.2G.AAFG,NEW PRIMARY TUMOR,TESTES,NA,2495
7,67DCDE6D-E247-402E-AB27-BA2832B2CC3B,TCGA.2G.AAFJ,BIOCHEMICAL EVIDENCE OF DISEASE,NA,NA,313
8,894B81B8-E98E-4ECB-B4E0-4C1C9AD97957,TCGA.2G.AAFL,NEW PRIMARY TUMOR,TESTES,NA,38
9,894B81B8-E98E-4ECB-B4E0-4C1C9AD97957,TCGA.2G.AAFL,DISTANT METASTASIS,LUNG,NA,130
10,251B5341-405F-4F16-8334-475F2D358C25,TCGA.2G.AAG0,DISTANT METASTASIS,LUNG,NA,90
11,A789B81C-3D8F-42A6-80B9-AE2AB4DF34E9,TCGA.2G.AAG3,NEW PRIMARY TUMOR,LUNG,NA,181
12,A789B81C-3D8F-42A6-80B9-AE2AB4DF34E9,TCGA.2G.AAG3,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,414
13,31356D96-F0A1-4A17-895F-89720C264377,TCGA.2G.AAG5,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,451
14,1B67D80C-335E-4094-B973-E8C064C6BF59,TCGA.2G.AAGC,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,317
15,626C1CB7-05F6-4DB1-A809-F6FCBA2CCE8E,TCGA.2G.AAGE,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,121
16,8F734F5C-FE5C-4C81-98C9-F88A8CA4A5EE,TCGA.2G.AAGF,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,139
17,8062CA27-542F-4A00-A047-C88B9B26F34F,TCGA.2G.AAGI,NEW PRIMARY TUMOR,TESTES,NA,2193
18,4E7EB78E-A4E2-463E-A3A0-54E128108031,TCGA.2G.AAGJ,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,171
19,A1A4313C-9C5B-432C-A879-5425898FFAEE,TCGA.2G.AAGK,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,713
20,320995DF-9EF7-460C-AA37-E232E2D4E327,TCGA.2G.AAGT,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,15
21,9ED4368B-AC80-419E-B6AD-1C70D56EF4E7,TCGA.2G.AAGX,NEW PRIMARY TUMOR,TESTES,NA,4323
22,9ED4368B-AC80-419E-B6AD-1C70D56EF4E7,TCGA.2G.AAGX,NEW PRIMARY TUMOR,OTHER, SPECIFY,BLADDER,5027
23,24718E25-4434-4054-861B-0B3E63FE506A,TCGA.2G.AAGY,NEW PRIMARY TUMOR,TESTES,NA,623
24,D0F2103B-A525-4AB4-A476-DF21623E756C,TCGA.2G.AAH0,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,107
25,D7D793F6-EAEA-4DD3-8237-C2C02B042340,TCGA.2G.AAHP,NEW PRIMARY TUMOR,TESTES,NA,816
26,43CC3C60-F0A6-4B44-BD7B-8EC4DA71991F,TCGA.2G.AAKG,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,122
27,43CC3C60-F0A6-4B44-BD7B-8EC4DA71991F,TCGA.2G.AAKG,NEW PRIMARY TUMOR,TESTES,NA,4616
28,3F0A06D1-4C45-46B8-A06D-036C8998342C,TCGA.2G.AAL5,NEW PRIMARY TUMOR,TESTES,NA,3723
29,18E7182D-16E8-4EFF-96EC-56FF241810D3,TCGA.2G.AAL7,BIOCHEMICAL EVIDENCE OF DISEASE,OTHER, SPECIFY,NA,9
30,588CC671-B7D3-492A-843B-F2E99F1E1109,TCGA.4K.AAAL,LOCOREGIONAL RECURRENCE,LYMPH NODE(S),NA,147
31,A9D8A9E3-2A0D-4DBD-808F-646A624D2E0A,TCGA.XE.AANJ,LOCOREGIONAL RECURRENCE,OTHER, SPECIFY,RPLN, LT SPERMATIC CORD; LT INGUINAL RING,328
32,11D10254-3A16-4526-98E8-80838F8427F2,TCGA.XE.AANV,DISTANT METASTASIS,LYMPH NODE(S),NA,1387
33,7DB75A66-3E9D-40E1-93C0-23F3630D6A9C,TCGA.XE.AAOB,DISTANT METASTASIS,LYMPH NODE(S),NA,231
34,7DB75A66-3E9D-40E1-93C0-23F3630D6A9C,TCGA.XE.AAOB,DISTANT METASTASIS,LIVER,NA,432
35,7DB75A66-3E9D-40E1-93C0-23F3630D6A9C,TCGA.XE.AAOB,DISTANT METASTASIS,LUNG,NA,432
36,7DB75A66-3E9D-40E1-93C0-23F3630D6A9C,TCGA.XE.AAOB,DISTANT METASTASIS,LYMPH NODE(S),NA,432
37,F18E8E44-6DCA-4588-A003-77D70D6E6866,TCGA.XE.AAOJ,LOCOREGIONAL RECURRENCE,OTHER, SPECIFY,MATURE TERATOMA: ABDOMINAL WALL,266
38,29B8C1F6-8478-40DB-A182-4EF15154A33D,TCGA.YU.AA4L,LOCOREGIONAL RECURRENCE,RETROPERITONEAL LYMPH NODES,NA,105
